Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4972929 | 0.86 | APP (0.39) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL918752 | 0.83 | LMNA (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL11140851 | 0.82 | PTGS1 (0.32) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL4404059 | 0.81 | LMNA (0.35) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL4883135 | 0.80 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL9001044 | 0.77 | LMNA (0.37) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL4736677 | 0.77 | PTGS1 (0.32) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL4198614 | 0.74 | PTGS1 (0.33) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL24451378 | 0.74 | ALDH1A1 (0.37) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL3836606 | 0.73 | PTGS1 (0.32) | PTGS1PDE4ALMNASLC6A6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1335886-B1 | SIZING COMPOSITION | CHEMTURA CORP (US) | 2007-08-08 | — | — | EP | claimed |
| EP-0867558-B1 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KK (JP) | 2006-10-18 | — | — | EP | claimed |
| EP-0592242-B1 | Fibrin sealant compositions and method for utilizing same | SQUIBB & SONS INC (US) | 2003-07-09 | — | — | EP | claimed |
| US-6200667-B1 | INK-JET PRINTING A CLOTH OF COTTON OR SILK FIBER USING A REACTIVE DYE AND A COMPOUND(S) OF PYRIDINE-3-CARBOXYLIC ACID, BISHYDROXYETHYL-TAURINE, HIPPURIC ACID, BENZOYLTAURINE; NONBLEEDING COLOR INTENSITY; CLARITY | CANON KABUSHIKI KAISHA (JP) | 2001-03-13 | — | — | US | claimed |
| EP-0867558-A2 | Cloth for textile printing, textile printing process using the cloth and print obtained thereby | CANON KABUSHIKI KAISHA (JP) | 1998-09-30 | — | — | EP | claimed |
| US-5750657-A | Methods and compositions using fibrin monomer to make a fibrin sealant | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-12 | — | — | US | claimed |
| EP-0592242-A1 | Fibrin sealant compositions and method for utilizing same | E.R. SQUIBB & SONS, INC. (US) | 1994-04-13 | — | — | EP | claimed |
| JP-3200828-A | — | — | None | — | — | JP | disclosed |
| US-12194494-B2 | Method for applying multi-layered coat onto automotive component molded product | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2025-01-14 | — | — | US | disclosed |
| US-12171785-B2 | Pluripotent cells derived from bone marrow and methods for isolation | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-12-24 | — | — | US | disclosed |
| US-20230374339-A1 | BASE COATING MATERIAL COMPOSITION AND COATED ARTICLE | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230372969-A1 | METHOD FOR APPLYING MULTI-LAYERED COAT ONTO AUTOMOTIVE COMPONENT MOLDED PRODUCT | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230302058-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | CELULARITY INC. (US) | 2023-09-28 | — | — | US | disclosed |
| US-4957850-A | Photosensitive flexographic resin plate | NIPPON PAINT CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4812335-A | METALLIC PIGMENT, WET-ON-WET, TWO-COAT, ONE-BAKE | NIPPON PAINT CO., LTD. (JP) | 1989-03-14 | — | — | US | disclosed |
| EP-0266152-A2 | Method of painting | Nippon Paint Co., Ltd. (JP) | 1988-05-04 | — | — | EP | disclosed |
| EP-0251228-A2 | Photosensitive flexographic printing plate | Nippon Paint Co., Ltd. (JP) | 1988-01-07 | — | — | EP | disclosed |
| EP-0169074-A2 | Treatment of subterranean formations | HALLIBURTON COMPANY (US) | 1986-01-22 | — | — | EP | disclosed |
| US-4563291-A | Method of preparation of substituted amino-alkyl sulfonic acid compounds and use in the treatment of subterranean formations | HALLIBURTON COMPANY (US) | 1986-01-07 | — | — | US | disclosed |
| US-4368287-A | POLYESTER CONTAINING AMINO-SULFONIC AMPHOIONIC GROUP | NIPPON PAINT CO., LTD. (JP) | 1983-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302058-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | PGF, CDH1, CXCL12 | PTGS1 174/4885PDE4A 2793/4885LMNA 3803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.